Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:989-994

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plaisance, P.
Right arrow Articles by Payen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plaisance, P.
Right arrow Articles by Payen, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON DIOXIDE
Medline Plus Health Information
*CPR
Related Collections
Right arrow Other heart failure
Right arrow CPR and emergency cardiac care

(Circulation. 2000;101:989.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Inspiratory Impedance During Active Compression-Decompression Cardiopulmonary Resuscitation

A Randomized Evaluation in Patients in Cardiac Arrest

Patrick Plaisance, MD; Keith G. Lurie, MD; Didier Payen, MD, PhD

From the Department of Anesthesiology and Critical Care (P.P., D.P.), Lariboisière University Hospital, Paris, France; and the Cardiac Arrhythmia Center, Cardiovascular Division (K.G.L.), University of Minnesota, Minneapolis.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Blood pressure is severely reduced in patients in cardiac arrest receiving standard cardiopulmonary resuscitation (CPR). Although active compression-decompression (ACD) CPR improves acute hemodynamic parameters, arterial pressures remain suboptimal with this technique. We performed ACD CPR in patients with a new inspiratory threshold valve (ITV) to determine whether lowering intrathoracic pressures during the "relaxation" phase of ACD CPR would enhance venous blood return and overall CPR efficiency.

Methods and Results—This prospective, randomized, blinded trial was performed in prehospital mobile intensive care units in Paris, France. Patients in nontraumatic cardiac arrest received ACD CPR plus the ITV or ACD CPR alone for 30 minutes during advanced cardiac life support. End tidal CO2 (ETCO2), diastolic blood pressure (DAP) and coronary perfusion pressure, and time to return of spontaneous circulation (ROSC) were measured. Groups were similar with respect to age, gender, and initial rhythm. Mean maximal ETCO2, coronary perfusion pressure, and DAP values, respectively (in mm Hg), were 13.1±0.9, 25.0±1.4, and 36.5±1.5 with ACD CPR alone versus 19.1±1.0, 43.3±1.6, and 56.4±1.7 with ACD plus valve (P<0.001 between groups). ROSC was observed in 2 of 10 patients with ACD CPR alone after 26.5±0.7 minutes versus 4 of 11 patients with ACD CPR plus ITV after 19.8±2.8 minutes (P<0.05 for time from intubation to ROSC).

Conclusions—Use of an inspiratory resistance valve in patients in cardiac arrest receiving ACD CPR increases the efficiency of CPR, leading to diastolic arterial pressures of >50 mm Hg. The long-term benefits of this new CPR technology are under investigation.


Key Words: cardiopulmonary resuscitation • heart arrest • circulation • active compression-decompression


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Active compression-decompression (ACD) cardiopulmonary resuscitation (CPR) was recently introduced as an alternative to standard manual CPR.1 2 3 4 Founded on the principle that active chest wall decompression during ACD CPR would enhance negative intrathoracic pressure during the "relaxation" phase and thereby increase venous return, this method of CPR has been reported to increase CPR efficiency in both animal models and in patients in cardiac arrest.1 2 3 4 5 6 7 More recently, we recognized the importance of impedance to inspiration during ACD CPR in order to further enhance the negative pressure during the decompression phase.4 8 9 On the basis of a mechanism similar to the clinical Mueller maneuver, inspiratory impedance has been demonstrated to increase vital organ blood flow by >50% using either standard or ACD CPR in a porcine model of ventricular fibrillation.8 9 Building on the results of ACD CPR in France, where hospital discharge rates were found to be significantly improved with ACD CPR compared with standard CPR,7 we evaluated the potential benefit of ACD CPR plus a new inspiratory impedance threshold valve (ITV) in patients with out-of-hospital cardiac arrest. In this prospective and blinded pilot study, subjects were randomized to receive either ACD CPR alone or ACD CPR plus the valve. Acute hemodynamic parameters were evaluated.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
This study was performed in Paris France in October 1997 after receiving approval from the Consultative Council for the Protection of Persons volunteering for Biomedical Research. The prehospital emergency response chain of survival in Paris, France is 2-tiered, as recently described.7 After receiving a call for help, a basic life support (BLS) vehicle and a mobile intensive care unit (MICU) were simultaneously dispatched to the scene. Because of a greater number of BLS vehicles covering a given region, they were frequently closer to the patient and could start BLS before the arrival of the MICU. There were at least 3 emergency medical technicians (EMTs) in each BLS vehicle together with a chief. As recommended by the Utstein style, BLS was not performed in patients with irreversible death ("decapitation, incineration, decomposition, rigor mortis, or dependent cyanosis") or do-not-resuscitate orders.10 BLS was performed with ACD CPR according to the recommendations of the manufacturer (Ambu Inc, Glostrup, Denmark) and of Wik et al11 and Schneider et al.12 Members of the rescue team performed ACD CPR for 3 to 5 minutes and then alternated to avoid fatigue. ACD CPR was performed at a rate of 90 compressions-decompressions per minute, controlled by a metronome. Ventilation was performed with a bag-mask system with supplemental O2.

The MICU staff included 5 persons. A MICU physician (anesthesiologist or general practitioner specially trained in emergency medicine), a nurse anesthetist, a medical student, and an ambulance driver managed the patient and helped for the performance of the protocol. In addition, there was another physician (anesthesiologist) at the scene to coordinate the research protocol. According to standard guidelines governing the French EMS system, patients with known terminal illness or in whom the delay between cardiac arrest and basic CPR exceeded 30 minutes did not receive advanced life support (ALS) CPR. Patients younger than 18 years old and those with hypothermia or thoracic trauma were also excluded from the study. The BLS and ALS teams worked together under the supervision of the EMT chief and the MICU physician. The ALS team also performed ACD CPR.

Evaluation of the rhythm was made by the MICU staff. For patients in ventricular fibrillation, European Resuscitation Council as well as American Heart Association guidelines were followed.13 14 For patients in asystole and pulseless electrical activity, ACD CPR was performed continuously by the MICU staff for a minimum of 30 minutes, unless return of spontaneous circulation was achieved. No attempt was routinely made to try to pace patients who were in asystole during the resuscitation effort. Epinephrine (1 mg) was administered every 5 minutes throughout the resuscitation effort.

All patients were intubated with an endotracheal tube on arrival of the MICU team. Following intubation, patients were mechanically ventilated with a compressible ventilator bag (Ambu Spur, Ambu Inc) with 100% oxygen. Ventilation was provided with 10 L/min oxygen, at a rate of 15 breaths/min with a tidal volume of {approx}10 mL/kg of patient’s weight. Monitoring of tidal volume was made by a spirometer of Wright fixed just before the inspiratory part of the ventilation bag valve. The impedance valve (ITV Resusci-Valve, provided by CPRxLLC, Minneapolis, Minn) was placed between the endotracheal tube (just distal to the antibacterial filter) and the connection port of the ventilator bag (Figure 1Down). This valve comprises a highly compliant silicone diaphragm, a fenestrated mount, and a safety "pop-off" valve attached to the side of the device and set to open when the intra-thoracic pressure decreases below -22 cm H20. The principle of the valve is to completely occlude the endotracheal tube when the pressure within the thorax is below atmospheric pressure. As such, the valve prevents inspiratory gas exchange only during the decompression phase, except during the time that active ventilation is being performed by the rescuer. In practice, when the patient is actively ventilated with the ventilator bag, oxygen is passed through the fenestrated mount of the valve during insufflation directly into the endotracheal tube without any significant impedance. When active ventilation is not performed, the silicone diaphragm occludes the airway whenever the intrathoracic pressure is <0 cm of water, ie, during the active decompression phase. During exhalation and during the compression phase of CPR, respiratory gases pass in the reverse direction, pushing the silicone diaphragm out of the way without any resistance by the valve.



View larger version (94K):
[in this window]
[in a new window]
 
Figure 1. A prototypic inspiratory impedance threshold valve (ITV) is shown. During the protocol, it was connected in series to an ETCO2 sensor, Wright spirometer, and the ventilation bag. The arrow was always pointed in the "CPR Yes" position. When actively ventilating the patient during ACD CPR, there was no resistance to inspiration. However, when not actively ventilating the patient during CPR, the impedance valve prevented inspiratory gas exchange during chest decompression, thereby lowering intrathoracic pressure. When the negative intrathoracic pressure exceeded -22 cm H2O, a safety check valve opened to minimize acute barotrauma and negative pressure pulmonary edema. During chest compression, there was no resistance to exhalation. Once the patient was resuscitated, the valve was removed, thereby removing all inspiratory resistance.

Using a computer-generated randomization chart, some of the valves were either enabled with the silicone diaphragm (ACD + ITV group) or disabled and the diaphragm was removed (ACD alone group). During the protocol study, it was not possible for the MICU staff to determine by visual inspection whether or not the silicone diaphragm was in place or had been removed. As such, they were blinded to use of the investigational device. When the diaphragm is removed, the valve does not impede inspiration, as there is a completely open conduit between the ventilator bag and the endotracheal tube. As such, gas exchange is not impaired and inhalation and exhalation are performed without any significant resistance. The randomization assignment was made before the beginning of the protocol by the hospital sterilization service. During performance of CPR and throughout the subsequent hospitalization, investigators were blinded to whether the impedance valve did or did not contain a functional diaphragm. After each use by the MICU staff, the valve was brought to this service for cleaning, and the sterile valve was then returned to the study physician in a bag with or without the diaphragm according to the randomization list.

Once patients were intubated by the MICU physician, a peripheral intravenous line was placed for drug administration. Femoral arterial (Seldicath, 5F, 12 cm, Plastimed, France) and venous cannula were placed sequentially by the study physician. A central venous cannula (2F, 60 cm, Seldiflex, Plastimed, France) introducer sheath was advanced 60 cm in the cranial direction in order to position the distal tip into the thoracic portion of the inferior vena cava. Arterial and central venous pressures were continuously monitored with heparinized fluid-flushed tubing to transducers (Sorensen Transpac III, Abbott Systems) and a monitoring system (Propac Encore, Physiocontrol). Transducers were calibrated and fixed to the midaxillary line of the patient. End tidal CO2 (ETCO2) was monitored continuously after intubating the patients with a capnometer (Normocap, Datex). Data from each patient were collected and analyzed to determine the ETCO2 and the arterial and right atrial pressures. The coronary perfusion pressure was calculated as the mathematical difference between arterial and right atrial pressures at the end of the relaxation phase of CPR.9 15 Hemodynamic parameters were monitored simultaneously at both catheters sites, and measurements were made every 5 minutes, just before a new epinephrine injection. If return of spontaneous circulation was achieved, CPR was discontinued and the impedance valve was removed. Patients were then ventilated with a portable volumetric ventilator (AXR1, Airox, France) and transported to the nearest inpatient hospital intensive care unit facility. All data regarding the resuscitation effort as well as postresuscitation clinical care were collected according to the Utstein Conference guidelines.10 Return of spontaneous circulation was defined as the presence of a palpable pulse in the absence of active chest compressions. Neurological outcome was evaluated using the cerebral performance category score system.10 Autopsies were not performed on the deceased.

All values are expressed as mean±SEM. Statistical analysis was performed for comparisons between groups using an unpaired 2-tailed Student’s t test. Statistical significance was considered to be at P<0.05. The 95% CI was also calculated for the mean difference between groups.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Thirty-three consecutive patients in cardiac arrest were eligible for the study protocol. Three patients were excluded because they had a return of spontaneous circulation (ROSC) within the first 10 minutes after intubation (2 ACD alone patients, 1 ACD plus valve patient) and consequently, no hemodynamic measurements could be performed. The first recorded rhythm in all patients was obtained at the time of the arrival of the mobile intensive care vehicle, {approx}20 minutes after cardiac arrest. Five patients in asystole and 4 patients in ventricular fibrillation were also excluded because simultaneous femoral arterial and venous access could not be obtained within 10 minutes (6 in the ACD alone group, 3 in the ACD plus valve group). Twenty-one patients were prospectively enrolled in this study. Ten patients were randomized to the ACD CPR group and 11 were randomized to receive ACD CPR plus valve. As shown in Table 1Down, the groups were similar in terms of gender, age, suspected cardiac etiology of cardiac arrest, initial rhythm, percentages of witnessed cardiac arrests and bystander CPR, and time intervals from collapse to arrival of BLS and ALS.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline Characteristics of the Patients Assigned to Active Compression-Decompression (ACD) or ACD Plus an Impedance Threshold Valve (ACD+ITV) CPR

As shown in Figure 2Down, ETCO2 levels were similar at the time of intubation (t=0), but rose more rapidly and to higher peak values in the ACD plus valve group compared with ACD CPR alone. These data include all ETCO2 measurements while patients were receiving CPR. In the ACD alone group, mean ETCO2 (mean±SEM) levels increased from 6.6±2.3 to 13±0.9 mm Hg during CPR, whereas in the ACD plus valve group, ETCO2 increased from 6.9±0.5 to 19.1±0.9 mm Hg (P<0.001 comparing maximum values). The 95% CIs for comparison of baseline ETCO2 values between groups were 1.6, 2.2 and 2.2, 9.2 for maximal values during CPR. There were fewer data points in the later time periods because some patients were resuscitated. As shown in the insert of Figure 2Down, in individual patients that were resuscitated, ETCO2 increased to >20 mm Hg, at which point asystole converted spontaneously to a stable blood perfusing rhythm. In these patients, sinus rhythm was restored and no additional CPR was required. This process occurred more rapidly in the impedance valve group. No patient with an ETCO2 <20 mm Hg was resuscitated during the 30-minute period of ACD CPR after intubation.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. ETCO2 levels for patients receiving ACD CPR plus the ITV (n=11) vs ACD CPR alone (n=10) are compared. At time of intubation (t=0), ETCO2 levels in both groups were similar. Within minutes, there was a significantly more rapid rise and greater increase in peak ETCO2 levels in the ACD CPR plus valve group when compared with ACD CPR alone (P<0.001 for peak values). n represents the number of patients still in cardiac arrest at each time point. Insert graph shows data from each patient who survived in each group (solid symbols represent ACD+valve; open symbols, ACD alone).

At the time the invasive monitoring was initiated (t=10 minutes), there were marked differences between groups when comparing the arterial pressures (Figure 3Down). There was no evidence for a compression phase gradient between the arterial and right atrial pressures. The mean peak arterial pressures, which were observed 10 minutes after intubation in both groups, were 90±6.4 mm Hg in the ACD CPR alone group versus 108±3.1 in the valve group (P<0.05). The maximal mean diastolic arterial pressure in the ACD CPR plus valve group was 56.4±1.7 mm Hg versus 36.5±1.5 mm Hg in the ACD alone group (P<0.001; 95% CI, 14.3, 23.8). Patients who had ROSC (Figure 3Down insert) had higher diastolic arterial pressures in the ACD CPR plus valve group compared with ACD CPR alone. A comparison between the coronary perfusion pressures in patients treated with ACD plus valve CPR versus ACD CPR alone is shown in Figure 4Down. The maximal diastolic coronary perfusion pressure with ACD CPR plus valve was 43±1.6 mm Hg versus 25.3±1.8 mm Hg for ACD CPR alone (P<0.001; 95% CI, 12.4, 22.8). The mean coronary perfusion pressure was 70% higher in the ACD CPR plus valve group when compared with the group given ACD CPR alone. With ACD CPR plus valve, patients with a coronary perfusion pressure >40 mm Hg appeared to have a greater likelihood of ROSC.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Diastolic arterial pressures (DAP) were measured in patients treated with ACD CPR plus ITV vs patients receiving ACD CPR alone. DAP were measured 10 minutes after patients underwent endotracheal intubation. DAP were significantly higher in the ACD plus impedance valve treatment group when compared with those who received ACD CPR alone (P<0.001 for peak values). n represents the number of patients in cardiac arrest at each time point. Insert graph shows data from each patient who survived in each group (solid symbols represent ACD+valve; open symbols, ACD alone).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4. Coronary perfusion pressures, calculated by the difference between diastolic femoral arterial and central venous pressures, were measured in patients with out-of-hospital cardiac arrest during ACD CPR alone (n=10) or during ACD CPR with an inspiratory threshold valve (n=11). n represents the number of patients still in cardiac arrest at each time point. Once return of spontaneous circulation was achieved, coronary perfusion pressures were no longer plotted. Patients were intubated at t=0 minutes, {approx}20 minutes after collapse, and the coronary perfusion pressures were recorded beginning 10 minutes later, once a femoral venous and a femoral arterial catheter were positioned. Coronary perfusion pressures were significantly higher in the ACD plus impedance valve treatment group vs those who received ACD CPR alone (P<0.001 for peak values). Insert graph shows data from each patient who survived in each group (solid symbols represent ACD+valve; open symbols, ACD alone).

In the present study, the first recorded rhythm for all the patients was asystole. Results related to time from intubation to ROSC, survival to 24 hour, survival after day 30, and survival to hospital discharge without neurological impairment are also shown in Table 2Down for both groups of patients. There was a significant reduction in the time between intubation and ROSC in the valve group (n=4; t=19.8±2.8 minutes) versus ACD alone group (n=2; t=26.5±0.7 minutes) (P=0.03).


View this table:
[in this window]
[in a new window]
 
Table 2. Outcomes of Patients Assigned to ACD or ACD+ITV CPR


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
This preliminary evaluation of a new inspiratory threshold valve focused on the acute hemodynamic effects of this valve during the performance of ACD CPR. Use of an impedance threshold valve to augment decompression phase-negative intrathoracic pressure during performance of ACD CPR resulted in a significant improvement in overall CPR efficacy. ETCO2, systolic and diastolic arterial pressures, and coronary perfusion pressure were all higher when compared with ACD CPR alone. The mean diastolic blood pressures were >50 mm Hg in the ACD plus valve group. Results from this first demonstration of the use of an impedance valve during CPR in humans in cardiac arrest are similar to those we have previously observed in animal studies,8 9 whereas the hemodynamic values found in the ACD CPR alone group are comparable with other human studies.16 In addition to improving hemodynamics, 4 of 11 patients had a ROSC with the use of ACD CPR plus the impedance valve after a significantly shorter period of total CPR time (19.8±2.8 minutes), compared with 2 of 10 patients with ACD alone after a longer total CPR time (26.5±0.7 minutes).

ETCO2 has previously been used as a surrogate for cardiac output and blood flow through the lungs, although it is affected both by blood flow and by minute ventilation.17 The measurement of ETCO2 as a surrogate for survival depends on several parameters, especially on minute ventilation. It has been previously shown that ACD CPR increased minute ventilation even during mechanical ventilation as compared with standard CPR.18 19 As such, measures of ETCO2 may be underestimated with ACD CPR.20 In contrast, because the impedance valve impedes gas exchange except during active manual ventilation, measured ETCO2 during ACD CPR plus the valve may be overestimated. Nonetheless, in the present study the higher ETCO2 values observed in the valve group were associated with a significant improvement in hemodynamic variables, such as systolic and diastolic arterial and coronary perfusion pressures and a shorter time between intubation and ROSC.

Information related to the initial cardiac rhythm in Paris is not known until the arrival of the ALS team, about 13 minutes after initiation of BLS CPR. In the present study the first recorded rhythm was asystole in all patients. This rhythm is generally associated with the worst outcome.7 21 22 However, recent studies from Paris, France, where >80% of patients were in asystole, have demonstrated that ACD CPR results in a significant improvement in a number of clinical outcomes, including hospital discharge rates (5.5%)7 21 and 1-year survival rates (4.6%)21 when compared with standard CPR (1.9%7 and 1.9%,21 respectively). As such, the hemodynamic improvement achieved by optimizing the bellows-like action of the chest with ACD CPR plus the impedance valve, as observed in the present study, suggest that patients in asystole may have an even greater chance for survival than previously considered.2

One of the limitations of the present study was that ACD CPR plus the valve could not be evaluated in patients with ventricular fibrillation, as we could not insert intravenous and arterial femoral lines in <10 minutes due to the multiple defibrillation attempts. Thus, although a benefit of the valve has previously been observed in animals,9 its potential value for patients in ventricular fibrillation remains unknown. A second limitation is that arterial blood gases were not measured in the present study. We have previously observed in the animal model that the partial pressure of arterial oxygen, PaO2, was decreased in the ACD CPR plus valve group relative to ACD CPR alone, although PaO2 values remained >95 mm Hg during CPR.9 Given the potential for decreased oxygenation despite active ventilation, PaO2 will have to be evaluated in the future. Another limitation is that femoral arterial pressures were used to calculate the coronary perfusion pressures instead of central aortic monitoring. We used a femoral arterial catheter because it is the standard of clinical practice in intensive care units. However, femoral arterial pressure measurements in cardiac arrest have been previously reported to be comparable with aortic pressures during both compression and relaxation phases of CPR in humans.23 Finally, due to previous lack of benefit associated with pacing patients in asystole in Paris, no efforts were made to externally pace the patients. Given the elevated diastolic arterial pressures and coronary perfusion pressures achieved with ACD CPR plus valve, pacing will be tried in future studies.

It is too early to know whether use of the impedance valve will improve the chances for long-term survival. This study was designed to evaluate acute hemodynamic parameters in patients with recent cardiac arrest in a well-controlled clinical environment. Larger prehospital studies are therefore needed to evaluate the likelihood of improved long-term survival with neurological recovery with this new technique. Nonetheless, this study demonstrates that use of an inspiratory impedance valve during CPR further optimizes mechanical measures associated with ACD CPR by increasing venous return and coronary perfusion pressures. Diastolic arterial pressures and coronary perfusion pressures recorded in this study with an impedance valve are >70% higher than those achieved with ACD CPR alone. These findings further underscore the importance of lowering intrathoracic pressure during the decompression phase of CPR. On the basis of these promising findings, prospective randomized clinical trials are underway to determine potential long-term value of combining ACD CPR with an impedance threshold valve in patients with cardiac arrest.


*    Acknowledgments
 
This study was partly supported by the Institutional Grant Program of Université Paris VII; UFR Lariboisière Saint-Louis.


*    Footnotes
 
Reprint requests to Patrick Plaisance, MD, Department of Anesthesiology and Critical Care, Lariboisière University Hospital, 2 Rue Ambroise Paré, 75475 Paris, France.

Dr Lurie is a co-inventor of the CardioPump, the device used to perform ACD CPR. Although the rights of the device are owned by the University of San Francisco, Dr Lurie was an employee of the University of California when the device was developed and is entitled to potential royalties from the sale of the device according to the rules and regulations of the Regents of the University of California. In addition, Dr Lurie is a co-inventor of the impedance threshold valve and has founded a company (CPRX) to develop the valve because the University of Minnesota Office of Research and Technology Administration was not interested in patenting the device.

Received April 30, 1999; revision received September 1, 1999; accepted September 17, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Cohen TJ, Tucker KL, Lurie KG, Redberg RF, Dutton JP, Dwyer KA, Schwab TM, Chin MC, Gelb AM, Scheinman MM, Schiller NB, Callaham ML. Active compression-decompression. A new method of cardiopulmonary resuscitation. JAMA. 1992;267:21:2916–2923.
  2. Lurie KG, Shultz JJ, Callaham ML, Schwab TM, Gisch T, Rector T, Frascone RJ, Long L. Evaluation of active compression-decompression CPR in victims of out-of-hospital cardiac arrest. JAMA. 1994;271:1405–1411.[Abstract]
  3. Chang MW, Coffeen P, Lurie KG, Voss G, Detloff B, Homans DC, White CW. Active compression-decompression CPR improves vital organ perfusion in a dog model of ventricular fibrillation. Chest. 1994;106:1250–1259.[Abstract/Free Full Text]
  4. Lurie KG. Active compression-decompression CPR: a progress report. Resuscitation. 1994;28:115–122.[Medline] [Order article via Infotrieve]
  5. Guly UM, Robertson CE. Active decompression improves the hemodynamic state during cardiopulmonary resuscitation. Br Heart J. 1995;73:372–376.[Abstract/Free Full Text]
  6. Pell ACH, Pringle SD, Guly UM, Steedamn DJ, Robertson CE. Assessment of the active compression-decompression device (ACD) in cardiopulmonary resuscitation using transesophageal echocardiography. Resuscitation. 1994;27:137–140.[Medline] [Order article via Infotrieve]
  7. Plaisance P, Adnet F, Vicaut E, Hennequin B, Magne P, Prudhomme C, Lambert Y, Cantineau JP, Leopold C, Ferracci C, Gizzi M, Payen D. Benefit of active compression-decompression cardiopulmonary resuscitation as a prehospital advanced cardiac life support: a randomized multicenter study. Circulation. 1997;95:955–961.[Abstract/Free Full Text]
  8. Lurie KG, Mulligan K, McKnite S, Deltoid B, Lindner K. Optimizing standard cardiopulmonary resuscitation with an inspiratory threshold valve. Chest. 1998;113:1084–1090.[Abstract/Free Full Text]
  9. Lurie KG, Coffeen PR, Shultz JJ, McKnite SH, Deltoid BS. Improving active compression-decompression cardiopulmonary resuscitation with an inspiratory impedance valve. Circulation. 1995;91:1629–1632.[Abstract/Free Full Text]
  10. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett P, Becker L, Bossaert L, Delooz H, Dick W, Eisenberg M. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Ann Emerg Med. 1991;20:861–874.[Medline] [Order article via Infotrieve]
  11. Wik L, Mauer D, Robertson C. The first European pre-hospital active compression-decompression (ACD) cardiopulmonary resuscitation workshop: a report and a review of ACD-CPR. Resuscitation. 1995;30:191–202.[Medline] [Order article via Infotrieve]
  12. Schneider T, Wik L, Baubin M, Dirks B, Ellinger K, Gisch T, Haghfelt T, Plaisance P, Vandemheen K. Active compression-decompression cardiopulmonary resuscitation: instructor and student manual for teaching and training, part I: the workshop. Resuscitation. 1996;32:203–206.[Medline] [Order article via Infotrieve]
  13. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA. 1992;268:2184–2234.[Medline] [Order article via Infotrieve]
  14. ALS working party of the European Resuscitation Council. Guidelines for advanced life support. Resuscitation. 1992;24:111–121.[Medline] [Order article via Infotrieve]
  15. Paradis NA, Martin GB, Goetting MG. Simultaneous aortic, jugular bulb, and right atrial pressures during cardiopulmonary resuscitation in humans. Circulation. 1989;80:361–368.[Abstract/Free Full Text]
  16. Shultz JJ, Coffeen P, Sweeney M, Detloff B, Kohler C, Pineda E, Yakshe P, Adler SW, Chang M, Lurie KG. Evaluation of standard and active compression-decompression CPR in an acute human model of ventricular fibrillation. Circulation. 89:684–693.
  17. Gudipati CV, Weil MH, Bisera J, Deshmukh HG, Rackow EC. Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation. 1988;77:234–239.[Abstract/Free Full Text]
  18. Tucker KJ, Khan JH, Savitt MA. Active compression-decompression resuscitation: effects on pulmonary ventilation. Resuscitation. 1993;26:125–131.[Medline] [Order article via Infotrieve]
  19. Carli PA, De La Coussaye JE, Riou B, Sassine A, Eledjam JJ. Ventilatory effects of active compression-decompression in dogs. Ann Emerg Med. 1994;24:890–894.[Medline] [Order article via Infotrieve]
  20. Orliaguet GA, Carli PA, Rozenberg A, Jannière D, Sauval P, Delpech PH. End-tidal carbon dioxide during out-of-hospital cardiac arrest resuscitation: comparison of active compression-decompression and standard CPR. Ann Emerg Med. 1995;25:48–51.[Medline] [Order article via Infotrieve]
  21. Plaisance P, Lurie KG, Vicaut E, Adnet F, Petit JL, Epain D, Ecollan P, Gruat R, Cavagna P, Biens J, Payen D, and the French ACD study group. A comparison of standard cardiopulmonary resuscitation versus active compression-decompression resuscitation for out-of-hospital cardiac arrest. N Engl J Med. 1999;341:599–75.
  22. Gueugniaud P, Mols P, Goldstein P, Pham E, Dubien P-Y, Deweerdt C, Vergnion M, Petit P, Carli P. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. N Engl J Med. 1998;339:1595–1601.[Abstract/Free Full Text]
  23. Rivers EP, Lozon J, Enriquez E, Havstad SV, Martin GB, Lewandowski CA, Goetting MG, Rosenberg JA, Paradis NA, Nowak RM. Simultaneous radial, femoral, and aortic arterial pressures during human cardiopulmonary resuscitation. Crit Care Med. 1993;21:878–883.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. A. Rickards, K. L. Ryan, W. H. Cooke, K. G. Lurie, and V. A. Convertino
Inspiratory resistance delays the reporting of symptoms with central hypovolemia: association with cerebral blood flow
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R243 - R250.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Srinivasan, V. M. Nadkarni, D. Yannopoulos, B. S. Marino, G. Sigurdsson, S. H. McKnite, M. Zook, D. G. Benditt, and K. G. Lurie
Rapid Induction of Cerebral Hypothermia Is Enhanced With Active Compression-Decompression Plus Inspiratory Impedance Threshold Device Cardiopulmonary Resusitation in a Porcine Model of Cardiac Arrest
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 835 - 841.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 6: CPR Techniques and Devices
Circulation, December 13, 2005; 112(24_suppl): IV-47 - IV-50.
[Full Text] [PDF]


Home page
CirculationHome page
Part 4: Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54.
[Full Text] [PDF]


Home page
CirculationHome page
D. Yannopoulos, V. M. Nadkarni, S. H. McKnite, A. Rao, K. Kruger, A. Metzger, D. G. Benditt, and K. G. Lurie
Intrathoracic Pressure Regulator During Continuous-Chest-Compression Advanced Cardiac Resuscitation Improves Vital Organ Perfusion Pressures in a Porcine Model of Cardiac Arrest
Circulation, August 9, 2005; 112(6): 803 - 811.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. B. Wolcke, D. K. Mauer, M. F. Schoefmann, H. Teichmann, T. A. Provo, K. H. Lindner, W. F. Dick, D. Aeppli, and K. G. Lurie
Comparison of Standard Cardiopulmonary Resuscitation Versus the Combination of Active Compression-Decompression Cardiopulmonary Resuscitation and an Inspiratory Impedance Threshold Device for Out-of-Hospital Cardiac Arrest
Circulation, November 4, 2003; 108(18): 2201 - 2205.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C. Raedler, W. G. Voelckel, V. Wenzel, L. Bahlmann, W. Baumeier, C. A. Schmittinger, H. Herff, A. C. Krismer, K. H. Lindner, and K. G. Lurie
Vasopressor Response in a Porcine Model of Hypothermic Cardiac Arrest Is Improved with Active Compression-Decompression Cardiopulmonary Resuscitation Using the Inspiratory Impedance Threshold Valve
Anesth. Analg., December 1, 2002; 95(6): 1496 - 1502.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. G. Lurie, W. G. Voelckel, T. Zielinski, S. McKnite, P. Lindstrom, C. Peterson, V. Wenzel, K. H. Lindner, N. Samniah, and D. Benditt
Improving Standard Cardiopulmonary Resuscitation with an Inspiratory Impedance Threshold Valve in a Porcine Model of Cardiac Arrest
Anesth. Analg., September 1, 2001; 93(3): 649 - 655.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
W. G. Voelckel, K. G. Lurie, T. Zielinski, S. McKnite, P. Plaisance, V. Wenzel, and K. H. Lindner
The Effects of Positive End-Expiratory Pressure During Active Compression Decompression Cardiopulmonary Resuscitation with the Inspiratory Threshold Valve
Anesth. Analg., April 1, 2001; 92(4): 967 - 974.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. B. Kern, H. R. Halperin, and J. Field
New Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care: Changes in the Management of Cardiac Arrest
JAMA, March 14, 2001; 285(10): 1267 - 1269.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plaisance, P.
Right arrow Articles by Payen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plaisance, P.
Right arrow Articles by Payen, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON DIOXIDE
Medline Plus Health Information
*CPR
Related Collections
Right arrow Other heart failure
Right arrow CPR and emergency cardiac care